A Prospective, Multi-center, Randomized Clinical Trial to Evaluate the Detection of Atrial Fibrillation Using Artificial Intelligence-Enhanced Electrocardiography (SmartECG-AFrisk) Compared With Usual Care in Patients With Suspected Atrial Fibrillation: DEEP-AF

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1230 participants.

Also called NCT07173673

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 1,230 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07173673
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07173673. Randomized; no masking; primary purpose diagnostic. Start 2025-11 (anticipated); primary completion 2027-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Prospective, Multi-center, Randomized Clinical Trial to Evaluate the Detection of Atrial Fibrillation Using Artificial Intelligence-Enhanced Electrocardiography (SmartECG-AFrisk) Compared With Usual Care in Patients With Suspected Atrial Fibrillation: DEEP-AF
Intervention (Other)
Usual Care (General Practice)
Intervention (Device)
AI-ECG Guided Care (SmartECG-AFrisk)
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct07173673
Content hash
fbb2286dd8f66f02a338ffba65478db659f51625241e49015665d04fe7464f64